Cardiovascular and bleeding risks of inactive cancer in patients with acute myocardial infarction who received primary percutaneous coronary intervention using drug-eluting stent and dual/triple antithrombotic therapy.
Journal Information
Full Title: Cardiovasc Diagn Ther
Abbreviation: Cardiovasc Diagn Ther
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Cardiac & Cardiovascular Systems
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of Interests: All authors have completed the ICMJE uniform disclosure form (available at https://cdt.amegroups.com/article/view/10.21037/cdt-22-306/coif). YK serves as an unpaid editorial board member of Cardiovascular Diagnosis and Therapy from September 2021 to August 2023, and has received research support from Nipro and Abbott, and honoraria from Nipro, Abbott, Kowa, Amgen, Sanofi, Astellas, Takeda and Daiichi-Sankyo. The other authors have no conflicts of interest to declare."
"Funding: None."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025